VOLTAREN TRANSDERMAL PATCH 0.015/DAY
VOLTAREN TRANSDERMAL PATCH 0.015/DAY - 2PCS
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Dosage Form: transdermal patch
Description: Rectangular plasters with rounded edges consisting of a beige polyester backing with a uniformly applied adhesive layer from colorless to pale yellow with a faint odor. The adhesive surface is covered with a transparent protective film of polyethylene with two transverse incisions, one of which has a wavy line. A pattern showing how to remove the film from the surface of the plaster is applied to the transparent protective film. The size of the patch is 70 x 100 mm.
Each transdermal patch 15 mg / day (70 cm ') contains:
Active ingredient: 15 mg of Diclofenac sodium (1%). Excipients: levomenthol 22.5 mg, methylpyrrolidone 60.0 mg, propylene glycol fatty acid esters 30.0 mg, citric acid 6.0 mg, isoprenstyrene copolymer 536.1 mg, polyisobutylene 30.0 mg, gum etherized 300.0 mg, mercaptobenzimidazole 3.7 mg, butylhydroxytoluene, 3.7 mg, liquid paraffin to 1500.00 mg; polyester fiber base (50 den) 70 cm5; polyester protective film (thickness 75 μm) 70 cm2.
Voltaren in the form of a transdermal patch is a base coated with an adhesive layer containing diclofenac, which has pronounced analgesic and anti-inflammatory properties. The basis of the mechanisms of action of diclofenac is inhibition of prostaglandin synthesis.
Voltaren's plaster provides anti-inflammatory and analgesic action at the site of application, eliminating pain and reducing the swelling associated with the inflammatory process.
Indications and usage
Back pain in inflammatory and degenerative diseases of the spine (radiculitis, osteoarthritis, lumbago, sciatica).
Pain in the joints (joints of the fingers, knee, etc.) in rheumatoid arthritis, osteoarthritis.
Muscle pain (due to sprains, overvoltages, bruises, injuries).
Inflammation and swelling of soft tissues and joints due to injuries and rheumatic diseases (tenosynovitis, bursitis, periarticular tissue lesions).
Hypersensitivity to diclofenac or other components of the drug; a tendency to the occurrence of asthma attacks, skin rashes or acute rhinitis with the use of Acetylsalicylic acid or other NSAIDs; pregnancy (III trimester); breastfeeding: children (up to 15 years); violation of the integrity of the skin in the place of alleged sticking the patch.
hepatic porphyria (exacerbation), erosive and ulcerative lesions of the gastrointestinal tract, severe impaired liver and kidney function, chronic heart failure, bronchial asthma, old age.
Pregnancy and Breastfeeding
The use of the drug in pregnant women has not been studied,
therefore, Voltaren Patch should not be used during pregnancy, especially in the third trimester, because of the possibility of reducing the tone of the uterus and / or premature closure of the fetal arterial duct. Animal studies have not revealed any direct or indirect negative effects on pregnancy, childbirth, fetal and postembryonic development. There is no data on the penetration of the drug into breast milk, so the Voltaren plaster is not recommended for use during breastfeeding.
Dosage and administration
Externally in the form of applications on the skin.
Voltaren plaster stick on the skin over
painful area for 24 hours. During the day
only 1 patch is allowed.
In the treatment of soft tissue damage plaster
Voltaren® is used no more
14 days, and in the treatment of diseases of the muscles and joints - not
more than 21 days if there are no special recommendations of the doctor.
If there is no improvement after 7 days and
with a deterioration of health, it is necessary
consult a doctor.
The use of Voltaren8 plaster in children under the age of 15 years is not recommended.
Similar to the method of use and doses for adults. Side effects
Undesirable reactions are mainly characterized by moderately pronounced and passing skin manifestations at the site of application of the patch. Very rare manifestations (<1/10000): Local reactions: pustular rash.Systemic reactions: generalized skin rash; allergic reactions (urticaria, hypersensitivity: angioedema, asthma, bronchospastic reactions), photosensitivity reactions. Rare (21 / 10000,1 / 1000): Local reactions: bullous dermatitis. Frequent manifestations (> 1/100, <1/10): Local reactions: erythema, dermatitis, incl. contact dermatitis (symptoms: erythema, pruritus, swelling of the treated skin area, rash, papules, vesicles, desquamation), eczema.
Extremely low systemic absorption of active ingredients and the dosage form of the drug for external use makes overdose almost impossible.
Interaction with other drugs
Voltaren® plaster may enhance the effect of drugs that cause photosensitization. Clinically significant interactions with other drugs are not described.
Influence on ability of driving of motor transport and control of mechanisms
The drug does not affect the speed of psychomotor reactions when driving and working with mechanisms.
The Voltaren Patch should be applied only to intact skin, avoiding contact with open wounds. Do not allow contact with the eyes and mucous membranes.
When applying the Voltaren patch for too long a time, the possibility of developing systemic adverse reactions cannot be excluded.
With the additional use of other dosage forms of diclofenac, its quantitative content in the patch should be considered in order not to exceed the maximum daily dose of diclofenac (150 mg / day).
Transdermal patch 15 mg / day (area 70 cmg). On 2,5,7 or 10 plasters in a package from aluminum foil.
Store at a temperature not higher than 25 "C in the original packaging.
Keep out of the reach of children.